J. Buchi

J.
Kevin Buchi is currently Chairman at Ampio Pharmaceuticals, Inc. since 2022.
He is an Independent Non-Executive Director at Benitec Biopharma Pty Ltd. and Benitec Biopharma, Inc. since 2013.
He serves as an Independent Director at Amneal Intermediate, Inc. since 2018 and at Amneal Pharmaceuticals, Inc. since 2023.
Former roles include President, Chief Executive Officer & Director at Cephalon LLC from 2010 to 2011; President, Chief Executive Officer & Director at BioSpecifics Technologies Corp.
from 2019 to 2020; President, Chief Executive Officer & Director at TetraLogic Pharmaceuticals Corp.
from 2013 to 2016; Chairman at Dicerna Pharmaceuticals, Inc. from 2019 to 2021; Director at Encysive Pharmaceuticals, Inc. from 2004 to 2008; Director at Aptose Biosciences, Inc. from 2003 to 2009; Director at Impax Laboratories LLC from 2017 to 2018; Independent Director at Alexza Pharmaceuticals, Inc. from 2013 to 2016; Director at Jazz Pharmaceuticals Therapeutics, Inc. from 2006 to 2010; Independent Director at Stemline Therapeutics, Inc. from 2012 to 2016; Director at Arana Therapeutics Ltd. in 2009; Director at ChemGenex Pharmaceuticals Pty Ltd.; Non-Executive Director at Mesoblast Ltd. from 2010 to 2012; Independent Director at Alaunos Therapeutics, Inc. from 2020 to 2021; Independent Director at Forward Pharma A from 2012 to 2016; Independent Director at Zalicus, Inc.; Director at EPIRUS Biopharmaceuticals, Inc. from 2013 to 2016 and Independent Director there from 2015 to 2016; Vice President-Global Branded Products at Teva Pharmaceutical Industries Ltd. from 2011 to 2012.
Education includes an undergraduate degree from Cornell University conferred in 1976 and a graduate degree from Kellogg School of Management conferred in 1980.